Samsung Affiliate Seeks European Approval for Near-Replica of Herceptin

October 4, 2016 2:27 AM

8 0

Samsung Affiliate Seeks European Approval for Near-Replica of Herceptin

Biosimilars are near-replicas of biologic drugs made from living cells

SEOUL—Samsung Group’s biologic drug development affiliate said Tuesday that it submitted a near-replica of blockbuster breast cancer drug Herceptin for regulatory approval in Europe, underscoring the South Korean conglomerate’s growing ambitions in the field of biosimilars.

Also read: Unilever Rejects Kraft Heinz's Initial Bid

Read more

To category page

Loading...